Thomson pharma clinical trials

Most of the questions have shown an average response. As many of the students take at least one research project of short term duration funded by our medical college and few funded by ICMR. Students have presented their research work at National and International level, which boosts them to conduct more research. They are governed by the student research forum of our college.

There is also a student wing of medical ethics, where seminars on ethics are presented by the students. This could be the reason for their better awareness about clinical trials. The early involvement of undergraduate students in research will help them to make evidence based decisions for their future practice One of the reasons for less involvement of students in clinical research could be poor research knowledge and interest.

Due to time constraints of the physician, the undergraduate medical students prove to be a good population to assist the clinician investigators for conductance of trials and for documentation. We should develop a mandatory course on GCP and research ethics for every medical student. Clinical trial training conducted in an efficient manner will help to tide over issues regarding the credibility of clinical research being done in India, which has cropped up in recent times.

Students should be given small projects. Regarding concept of clinical trial and knowledge about clinical trial is similar to a study done by Kamal H Sharma 12 et al.

This could be due to various terms and types of clinical trials are partly covered in undergraduate pharmacology. If students are involved in research, it will help them to develop skills like literature search, collecting and analyzing data. To boost undergraduate research involvement, strategies like elective assignments can be given, to include student sections in journals, holding workshops and organizing student conferences.

One of the barriers for initiating clinical studies is cumbersome paperwork and time constraints. If there is a structured training for doctors in clinical trials, there would be a level of uniformity throughout country.

In our study around This could be due to the sensitization about pharmacovigilance in the undergraduate curriculum. In comparison to a similar study done on pharmacy students on awareness of clinical trials the medical students knowledge was better. This could be due to larger sample size in the present study. As some percent of medical undergraduates may be future investigators. Hence they need to be trained in their study period about clinical research and medical ethics.

As UM Thatte 16 has suggested to conduct clinical trials one need to have sound knowledge about basic principles of clinical research, ethical and regulatory requirements and good clinical practices. Innumerous administrative and regulatory requirements at all stages of a CT can cause significant delays in its initiation. Moreover, regulations can vary across countries and regions e.

New CTs often take over 6 months from protocol approval to activation of the trial. Such protracted timelines incur heavy costs and decrease overall trial efficiency.

As stated above, many trials are terminated because they fail to accrue enough participants. Data even indicate that CT timelines have potentially doubled because of low recruitment rates. Similarly, physician participation in CTs is also a major problem. However, this is not always easy as physicians have myriad concerns around participation in clinical research. Many physicians are unaware of ongoing trials or simply not interested in the study topic. This lack of interest may arise from unclear clinical and scientific rationales of studies.

Additionally, several physicians are hesitant about participating in CTs due to unfamiliarity with research methods and procedures and trial-specific communication difficulties.

Physicians can also be reluctant to act as referring physicians due to several reasons. For example, most of them do not have sufficient information about the relevant ongoing trials, many are not actively involved in research, and a few may fear being removed from the picture and losing their patients to the trial investigator physicians.

With the ever-increasing complexity of clinical research, lack of training for the participating physicians and their staff may prove to be a deterrent. Furthermore, insufficient administrative support—for paperwork, clerical activities, data management, etc. ON TRAX — Evaluating a mobile technology monitoring device used in patients with inoperable Stage 3 Lung Cancer Lung cancer is one of the leading causes of cancer deaths in men and women worldwide.

People […]. Clinical trials are how we discover new and superior treatments, better ways to prevent side effects, and improve survival rates for cancer patients. IMMU